UniProt ID | DNJB1_HUMAN | |
---|---|---|
UniProt AC | P25685 | |
Protein Name | DnaJ homolog subfamily B member 1 | |
Gene Name | DNAJB1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 340 | |
Subcellular Localization | Cytoplasm . Nucleus . Nucleus, nucleolus . Translocates rapidly from the cytoplasm to the nucleus, and especially to the nucleoli, upon heat shock. | |
Protein Description | Interacts with HSP70 and can stimulate its ATPase activity. Stimulates the association between HSC70 and HIP. Negatively regulates heat shock-induced HSF1 transcriptional activity during the attenuation and recovery phase period of the heat shock response. [PubMed: 9499401 Stimulates ATP hydrolysis and the folding of unfolded proteins mediated by HSPA1A/B (in vitro)] | |
Protein Sequence | MGKDYYQTLGLARGASDEEIKRAYRRQALRYHPDKNKEPGAEEKFKEIAEAYDVLSDPRKREIFDRYGEEGLKGSGPSGGSGGGANGTSFSYTFHGDPHAMFAEFFGGRNPFDTFFGQRNGEEGMDIDDPFSGFPMGMGGFTNVNFGRSRSAQEPARKKQDPPVTHDLRVSLEEIYSGCTKKMKISHKRLNPDGKSIRNEDKILTIEVKKGWKEGTKITFPKEGDQTSNNIPADIVFVLKDKPHNIFKRDGSDVIYPARISLREALCGCTVNVPTLDGRTIPVVFKDVIRPGMRRKVPGEGLPLPKTPEKRGDLIIEFEVIFPERIPQTSRTVLEQVLPI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | 2-Hydroxyisobutyrylation | -----MGKDYYQTLG -----CCCHHHHHHH | 41.06 | - | |
3 | Ubiquitination | -----MGKDYYQTLG -----CCCHHHHHHH | 41.06 | - | |
5 | Phosphorylation | ---MGKDYYQTLGLA ---CCCHHHHHHHHC | 10.85 | 28152594 | |
6 | Phosphorylation | --MGKDYYQTLGLAR --CCCHHHHHHHHCC | 12.73 | 28152594 | |
8 | Phosphorylation | MGKDYYQTLGLARGA CCCHHHHHHHHCCCC | 13.48 | 28152594 | |
13 | Methylation | YQTLGLARGASDEEI HHHHHHCCCCCHHHH | 46.37 | 115479707 | |
16 | Phosphorylation | LGLARGASDEEIKRA HHHCCCCCHHHHHHH | 48.67 | 28985074 | |
21 | Ubiquitination | GASDEEIKRAYRRQA CCCHHHHHHHHHHHH | 33.97 | - | |
21 | Succinylation | GASDEEIKRAYRRQA CCCHHHHHHHHHHHH | 33.97 | 23954790 | |
21 | Acetylation | GASDEEIKRAYRRQA CCCHHHHHHHHHHHH | 33.97 | 25953088 | |
31 | Phosphorylation | YRRQALRYHPDKNKE HHHHHHHHCCCCCCC | 20.68 | 29496907 | |
35 | Ubiquitination | ALRYHPDKNKEPGAE HHHHCCCCCCCCCHH | 74.50 | - | |
37 | Ubiquitination | RYHPDKNKEPGAEEK HHCCCCCCCCCHHHH | 71.65 | - | |
44 | Ubiquitination | KEPGAEEKFKEIAEA CCCCHHHHHHHHHHH | 53.92 | 19608861 | |
44 | 2-Hydroxyisobutyrylation | KEPGAEEKFKEIAEA CCCCHHHHHHHHHHH | 53.92 | - | |
44 | Acetylation | KEPGAEEKFKEIAEA CCCCHHHHHHHHHHH | 53.92 | 19608861 | |
46 | Ubiquitination | PGAEEKFKEIAEAYD CCHHHHHHHHHHHHH | 60.31 | - | |
52 | Phosphorylation | FKEIAEAYDVLSDPR HHHHHHHHHHHCCHH | 9.70 | - | |
58 | Ubiquitination | AYDVLSDPRKREIFD HHHHHCCHHHHHHHH | 40.07 | - | |
60 | Ubiquitination | DVLSDPRKREIFDRY HHHCCHHHHHHHHHH | 60.82 | - | |
66 | Methylation | RKREIFDRYGEEGLK HHHHHHHHHCCCCCC | 30.52 | 115479715 | |
67 | Phosphorylation | KREIFDRYGEEGLKG HHHHHHHHCCCCCCC | 30.63 | 29496907 | |
78 | Phosphorylation | GLKGSGPSGGSGGGA CCCCCCCCCCCCCCC | 60.35 | 25137130 | |
81 | Ubiquitination | GSGPSGGSGGGANGT CCCCCCCCCCCCCCC | 37.48 | - | |
88 | Phosphorylation | SGGGANGTSFSYTFH CCCCCCCCEEEEEEC | 26.80 | - | |
89 | Phosphorylation | GGGANGTSFSYTFHG CCCCCCCEEEEEECC | 17.37 | - | |
95 | Ubiquitination | TSFSYTFHGDPHAMF CEEEEEECCCCCHHH | 31.76 | - | |
95 | Acetylation | TSFSYTFHGDPHAMF CEEEEEECCCCCHHH | 31.76 | - | |
148 | Ubiquitination | FTNVNFGRSRSAQEP CCCCCCCCCCCCCCC | 25.43 | - | |
149 | Phosphorylation | TNVNFGRSRSAQEPA CCCCCCCCCCCCCCH | 30.85 | 29978859 | |
151 | Phosphorylation | VNFGRSRSAQEPARK CCCCCCCCCCCCHHH | 35.23 | 28102081 | |
158 | Ubiquitination | SAQEPARKKQDPPVT CCCCCHHHCCCCCCC | 57.82 | - | |
159 | Ubiquitination | AQEPARKKQDPPVTH CCCCHHHCCCCCCCH | 55.14 | - | |
171 | Phosphorylation | VTHDLRVSLEEIYSG CCHHHHHCHHHHHCC | 24.51 | 21945579 | |
176 | Phosphorylation | RVSLEEIYSGCTKKM HHCHHHHHCCCCCCC | 11.42 | 21945579 | |
177 | Phosphorylation | VSLEEIYSGCTKKMK HCHHHHHCCCCCCCC | 32.81 | 21945579 | |
180 | Phosphorylation | EEIYSGCTKKMKISH HHHHCCCCCCCCCCC | 36.91 | 21945579 | |
181 | 2-Hydroxyisobutyrylation | EIYSGCTKKMKISHK HHHCCCCCCCCCCCC | 55.75 | - | |
181 | Ubiquitination | EIYSGCTKKMKISHK HHHCCCCCCCCCCCC | 55.75 | - | |
181 | Acetylation | EIYSGCTKKMKISHK HHHCCCCCCCCCCCC | 55.75 | 25953088 | |
186 | Ubiquitination | CTKKMKISHKRLNPD CCCCCCCCCCCCCCC | 19.89 | - | |
186 | Phosphorylation | CTKKMKISHKRLNPD CCCCCCCCCCCCCCC | 19.89 | - | |
195 | Ubiquitination | KRLNPDGKSIRNEDK CCCCCCCCCCCCCCC | 50.52 | 21906983 | |
195 | 2-Hydroxyisobutyrylation | KRLNPDGKSIRNEDK CCCCCCCCCCCCCCC | 50.52 | - | |
195 | Acetylation | KRLNPDGKSIRNEDK CCCCCCCCCCCCCCC | 50.52 | 23749302 | |
196 | Phosphorylation | RLNPDGKSIRNEDKI CCCCCCCCCCCCCCE | 32.10 | 19651622 | |
202 | Ubiquitination | KSIRNEDKILTIEVK CCCCCCCCEEEEEEE | 33.18 | - | |
205 | Phosphorylation | RNEDKILTIEVKKGW CCCCCEEEEEEECCC | 20.68 | 21406692 | |
209 | 2-Hydroxyisobutyrylation | KILTIEVKKGWKEGT CEEEEEEECCCCCCC | 32.55 | - | |
217 | Ubiquitination | KGWKEGTKITFPKEG CCCCCCCEEECCCCC | 51.08 | - | |
222 | Ubiquitination | GTKITFPKEGDQTSN CCEEECCCCCCCCCC | 70.86 | - | |
227 | Phosphorylation | FPKEGDQTSNNIPAD CCCCCCCCCCCCCCE | 37.86 | 25693802 | |
228 | Phosphorylation | PKEGDQTSNNIPADI CCCCCCCCCCCCCEE | 23.42 | 21712546 | |
240 | Ubiquitination | ADIVFVLKDKPHNIF CEEEEEECCCCCCCC | 59.41 | - | |
242 | Acetylation | IVFVLKDKPHNIFKR EEEEECCCCCCCCCC | 46.73 | 26051181 | |
242 | Ubiquitination | IVFVLKDKPHNIFKR EEEEECCCCCCCCCC | 46.73 | - | |
248 | 2-Hydroxyisobutyrylation | DKPHNIFKRDGSDVI CCCCCCCCCCCCCCE | 45.87 | - | |
248 | Ubiquitination | DKPHNIFKRDGSDVI CCCCCCCCCCCCCCE | 45.87 | - | |
252 | Phosphorylation | NIFKRDGSDVIYPAR CCCCCCCCCCEEECC | 32.75 | 28152594 | |
256 | Phosphorylation | RDGSDVIYPARISLR CCCCCCEEECCCHHH | 7.23 | 28152594 | |
261 | Phosphorylation | VIYPARISLREALCG CEEECCCHHHHHHCC | 18.80 | - | |
286 | 2-Hydroxyisobutyrylation | RTIPVVFKDVIRPGM CEECEEEEHHCCCCC | 39.20 | - | |
286 | Ubiquitination | RTIPVVFKDVIRPGM CEECEEEEHHCCCCC | 39.20 | 21890473 | |
286 | Ubiquitination | RTIPVVFKDVIRPGM CEECEEEEHHCCCCC | 39.20 | 21890473 | |
286 | Acetylation | RTIPVVFKDVIRPGM CEECEEEEHHCCCCC | 39.20 | 25953088 | |
296 | Ubiquitination | IRPGMRRKVPGEGLP CCCCCCCCCCCCCCC | 42.28 | - | |
306 | Ubiquitination | GEGLPLPKTPEKRGD CCCCCCCCCCCCCCC | 81.85 | - | |
307 | Phosphorylation | EGLPLPKTPEKRGDL CCCCCCCCCCCCCCE | 34.44 | 25159151 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DNJB1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DNJB1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HSP7C_HUMAN | HSPA8 | physical | 10075921 | |
DNJC3_BOVIN | DNAJC3 | physical | 9920933 | |
HSP7C_RAT | Hspa8 | physical | 9920933 | |
PHLA1_HUMAN | PHLDA1 | physical | 17024176 | |
A4_HUMAN | APP | physical | 21832049 | |
PUR8_HUMAN | ADSL | physical | 22863883 | |
DPYL2_HUMAN | DPYSL2 | physical | 22863883 | |
PDE12_HUMAN | PDE12 | physical | 22863883 | |
UBQL2_HUMAN | UBQLN2 | physical | 22863883 | |
WDR4_HUMAN | WDR4 | physical | 22863883 | |
XPO7_HUMAN | XPO7 | physical | 22863883 | |
MDM2_HUMAN | MDM2 | physical | 24361594 | |
P53_HUMAN | TP53 | physical | 24361594 | |
DAG1_HUMAN | DAG1 | physical | 26344197 | |
ERF1_HUMAN | ETF1 | physical | 26344197 | |
HYOU1_HUMAN | HYOU1 | physical | 26344197 | |
PPID_HUMAN | PPID | physical | 26344197 | |
STIP1_HUMAN | STIP1 | physical | 26344197 | |
TTL12_HUMAN | TTLL12 | physical | 28514442 | |
DNJB5_HUMAN | DNAJB5 | physical | 28514442 | |
DCAF6_HUMAN | DCAF6 | physical | 28514442 | |
BGAL_HUMAN | GLB1 | physical | 28514442 | |
NUDC_HUMAN | NUDC | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-44, AND MASS SPECTROMETRY. |